Differential Expression of Senescence and Cell Death Factors in Non-Small Cell Lung and Colorectal Tumors Showing Telomere Attrition

被引:6
作者
Fernandez-Marcelo, Tamara [1 ,4 ]
Moran, Alberto [1 ,4 ]
de Juan, Carmen [1 ,4 ]
Pascua, Irene [1 ,4 ]
Head, Jacqueline [1 ,4 ]
Gomez, Ana [2 ,4 ]
Hernando, Florentino [2 ,4 ]
Lopez-Asenjo, Jose A. [5 ]
Hernandez, Susana [3 ,4 ]
Sanchez-Pernaute, Andres [2 ,4 ]
Torres, Antonio J. [2 ,4 ]
Benito, Manuel [1 ,4 ]
Iniesta, Pilar [1 ,4 ]
机构
[1] Univ Complutense, Dept Bioquim & Biol Mol 2, Fac Farm, ES-28040 Madrid, Spain
[2] Hosp Clin San Carlos, Serv Cirugia, Madrid, Spain
[3] Hosp Clin San Carlos, Serv Anat Patol, Madrid, Spain
[4] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain
[5] Hosp Principe Asturias, Serv Patol, Alcala De Henares, Spain
关键词
Telomeres; Telomerase; Senescence; Non-small cell lung cancer; Colorectal cancer; CHROMOSOMAL INSTABILITY; CANCER; LENGTH; CARCINOMA; PATHWAY; COLON; P53; PROGNOSIS; APOPTOSIS; DISEASE;
D O I
10.1159/000335678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The main aim of this work is to investigate the expression of factors related to senescence and cell death pathways in non-small cell lung cancers (NSCLCs) and colorectal cancers (CRCs) in relation to telomere status. Methods: We analyzed 158 tissue samples, 36 NSCLCs, 43 CRCs, and their corresponding control tissues obtained from patients submitted to surgery. Telomere function was evaluated by determining telomerase activity and telomere length. Expression of factors related to senescence, cell death pathways, transformation and tumorigenesis was investigated using arrays. Results were validated by real-time quantitative PCR. Results: Considering tumors with telomere shortening, expression for BNIP3, DAPK1, NDRG1, EGFR, and CDKN2A was significantly higher in NSCLC than in CRC, whereas TP53 was overexpressed in CRC with respect to NSCLC. Moreover, compared to nontumor samples, DAPK1, GADD45A, SHC1, and TP53 were downregulated in the group of NSCLCs with telomere shortening, and no significant differences were found in CRC. Conclusions: In NSCLC, the failure of pathways which involve factors such as DAPK1, GADD45A, SHC1, and TP53, in response to short telomeres, could promote tumor progression. In CRC, the viability of these pathways in response to short telomeres could contribute to limiting tumorigenesis.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 42 条
  • [1] Telomere states and cell fates
    Blackburn, EH
    [J]. NATURE, 2000, 408 (6808) : 53 - 56
  • [2] Switching and signaling at the telomere
    Blackburn, EH
    [J]. CELL, 2001, 106 (06) : 661 - 673
  • [3] Telomeres and human disease: Ageing, cancer and beyond
    Blasco, MA
    [J]. NATURE REVIEWS GENETICS, 2005, 6 (08) : 611 - 622
  • [4] The many faces of telomerase: emerging extratelomeric effects
    Bollmann, F. Mathias
    [J]. BIOESSAYS, 2008, 30 (08) : 728 - 732
  • [5] Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers
    Chang, Yih-Leong
    Wu, Chen-Tu
    Shih, Jin-Yuan
    Lee, Yung-Chie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) : 543 - 550
  • [6] Cretu Alexandra, 2009, Cancer Ther, V7, P268
  • [7] Role of telomeres and telomerase in genomic instability, senescence and cancer
    Deng, Yibin
    Chang, Sandy
    [J]. LABORATORY INVESTIGATION, 2007, 87 (11) : 1071 - 1076
  • [8] NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
    Ellen, Thomas P.
    Ke, Qingdong
    Zhang, Ping
    Costa, Max
    [J]. CARCINOGENESIS, 2008, 29 (01) : 2 - 8
  • [9] Increased NDRG1 Expression is Associated with Advanced T Stages and Poor Vascularization in Non-small Cell Lung Cancer
    Fan, Chuifeng
    Yu, Juanhan
    Liu, Yang
    Xu, Hongtao
    Wang, Enhua
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (03) : 549 - 556
  • [10] Short telomeres limit tumor progression in vivo by inducing senescence
    Feldser, David M.
    Greider, Carol W.
    [J]. CANCER CELL, 2007, 11 (05) : 461 - 469